A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia
Status:
Completed
Trial end date:
2017-02-15
Target enrollment:
Participant gender:
Summary
The purpose of this two-part study is to evaluate the safety and tolerability of the study
drug known as LY3202328 in healthy overweight participants in Part A, and those with
dyslipidemia (abnormal blood fats) in Part B.